Charity registration number 1084898 SINCOPE TRUST AND REFLEX ANOXIC SEIZURES ANNUAL REPORT AND UNAUDITED FINANCIAL sfATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 SYNCOPE TRU￿ AND REFLEX ANOXIC SEIZURES LEGAL AND ADMINISTRATIVE INFORMATION Trustees Dr. W P Whitehouse Mrs C L Reid E Bateson Dr M Asgari Charlty number 1084898 Prlnclpal address TC Group Celixir House Straford Bu5ine55 & Technology Park Innovation Way, Banbury Road Strarford-upon-Avon W3rwickshire CV37 7GZ Independent examiner TC Group Celixir House Strarford Business & Technology Park Innovation Way, Banbury Road Str3rford-upon-Avon Warwickshire United Kingdom CV37 7GZ SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES CONTENTS Page Trustees, report Independent examiner'5 report Statement of financial activities Balance sheet Notes to the financial statements 10-17 SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 The Trustees present their annual report and financial statements forthe year ended 31 December 2023. The financial statement5 hève been prepared in accordance with the accounting policies set out in note I to the financi31 statements and comply with the Charity's Igoverning document), the Charities Act 2011 and "AccountinE and Reporting by Charitie5.' Ststement of Recommended Practice applicable to charities preparing their a¢counts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021" leffertive l January 2019}. Objectives and activities The principal objertive5 of the charlty are: To alleviate the efferts of and provlde support and information on, syncope and reflex anoxic seizures, to those in distre55 as a result of these seizures, whether SLiffered by themselves or a5 a member of the family group. To advance the education of the medical profession and the general public on the subject of syncope and reflex anoxic seizures and its implications for the individual and family. To promote research into the management of Syncope and reflex anoxic seizure and to publish the useful results thereof and to suppcrt organisations promoting research into syncope and reflex seizures. There have been no changes to these objectives since the last annual repc>rt. Volunteers STARS utilises volunteers to assist in our work, Public benefit The Tru5tee5 have paid due regard to guidance issued by the Charity Commission in deciding what activities the Charity should undertake. The trustees confirm that they have complied with their duty under Section 4 of the Charities Art 2011 to have due regard to the Charity Commission's Eeneral guidance on public benefit. SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES TRusfEES' REPORT {cO￿riNUED1 FOR THE YEAR ENDED 31 DECEMBER 2023 Achievements and performance Significant Jctivities ond uchievernents ogain5t objectives STARS continue5 to be the only organisation globally dedicated to providing information, support, education and awareness on syncope, reflex anoxic seizures, POTS and related conditions. We are frequently requested to present at medical meetings, provide answers to schools about how to receive a child with RAS and to provide the necessary support to parents, caregivers, and families to help them better support the person living with the condition. Celebrating 30 years of STARS11993-20231 STARS was founded by Trudie Lobban M8E in March 1993 and was established at the request of a paediatric neurologist PrDfessor John Stephenson who gave a name to the unexplained loss of consciousness young children were experiencing - Reflex Anoxic Seizures. STARS began to build a collaboration of patients, carers. he31thcare professionals and policy makers aiming to spread the word and reduce misdiagn05is. STARS has a Medical Advisory Board, and all publications are reviewed and approved by them- it Is ￿COgniSed worldwide as the only organi5ation providing information, awareness, education and support to all those affected by syncope and related conditions. This year STARS celebrates its, 30th anniversary. Slnce that March day in 1993, STARS has had a huge impact nationally and internationally in raising awareness of syncope and unexplained loss of consciousness. There are two landmarks from many that deserve remembering. In 20DO, our Founder and CEO, Trudie Lobb3n established the first STAR5 Medical Advisory Committee {STARS MAC}. a multi-disciplinary committee that has been and will continue to be vital to our success. In 2004, the much-acclaimed STARS Blackouts Checklist was introduced to help individuals and their doctors reach a correct diagnosis. STARS US was introduced to America in 2007. This Chapter of the charity was 3 direct result of high demand from patients and rnedical professionals who had no comparable support of this nature in the US. To date STARS is now active in more than 30 countries. There is no such thing as o simple faint; Syncope is o symptom not o condition- takefointing to heort. Quotes that are synonymous with the campaigns STARS has run over the years and which have been instrumental in raising awareness and reducing misdiagnosis. 2009. 16 years after she first founded the charity, STARS Founder and CEO, Trudie Lobban was awarded the MBE in recognition of her work and campaigning for better detection, diagnosis and management of syncope and unexplained loss of consciousness. Countless lives have been saved due to the work of STARS as all too often the only Symptom pritsr to Sudden Cardiac Arrest is 'f3inting/loss of consciousness,. When 3 correct diagnosis is received the Correct treatment can be implemented and therefore those suffering from loss of ¢onsciousness and a potentially fatal heart rhythm disorder larrhythmial can be t￿ated thus avoiding Sudden Cardiac Death. STARS led the call to includln8 the addition of Chapter 8 to the National Service Framework on Coronary Heart Disease, Founder Trudie Lobban wa5 the first non-medical person to be invited by the Department of Hea5th to sit on the expert writin8 committee. Publication of NICE Transient Loss of Consciousness ITLOCI Guidelines was also Instigated by STARS and its Medical Advisory Committee, STARS with Trudie at its helm continues to be in much demand to present at national and international conferences STARS is represented on numerou5 research projects seeking to improve the diagn05i5 and treatment options for people living wrth syncope, RAS, POTS and unexplained loss of consciousness. SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRu¥fEES' REpoirr (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Supportln8 people living wlth Syncope, RAS and POTS STARS educational videos, resources, online forums arid other infomiation continue to deliver information, support, education. and awareness to all those affected by syncope and loss of consciousness. webina￿ were produced with guidance and contributlons from healthcare professionals, ensuring our material is up to date and informative for STARS audience. OvÈr 129,000 Individual views during 2023 Virtual coffee mornings An opportunity to talk to patients, caregiver5 and family members sharing experiences, and STARS team can provide rea55urance and guidance. STARS onllne meetings included topics such as-. Back to school or college? Reflex Anoxic seiiures (RASI Sept 2023 Syncope & falls in the elderly - Dec 2023 Llvln8 With RAS and Syncope - STARS continued throughout 2023 with its 'Living With... series patient video education on a range Df subjects which included new this year on the subject of POTS, all available online and free to register to watch. 2023 saw over 2000 registrations and reached audiences from all over the world. RalsSng avrdreness of syn¢ope and syncope-related condltlons - World Heart Rhythm Week 2023 STARS collaborates and supports the World Heart Rhythm hosted in June each year and organised by its Sister charity- Arrhythmia Alliance. For WHRW2023 supporters were encouraged to focus on sharing the connettion between fainting, syncope, misdiagnosi5 of epilepsy and Sudden Cardiac Arrest. By highlighting that syncope is a symptom often maskin8 potentl31 fatal underlying heart rhythm conditions STARS was able to ensure more people were aware and to seek medical advice and STARS resources if they suffer with unexplained loss of consciousness or have a history of sudden cardiac death in the family. We received support from hundreds of individuals, organisations, and healthcare professional around the globe. resulting in our campaign reaching many millions of people. WHRW2023 Palace of Westminster, London event was held as part of celebrating 30 years of STARS. It was only right that therefore the focus was on 'Take Fainting to Heart there is no such thing as a simple falnt,. WHRW2023 drew attention to the link between syncope and arrhythmias and how syncope is a symptom not a condition, however. should alway5 be investlgated in case there is an underlying. potentially fatsl, arrhythmia. The reception made sure thi5 important message was delivered. During the reception ot the Poloce of Westminster STARS Healthcore Pioneers Report 2023 was launched with the announcement of the winner5. The report highlights the innovative and inspiring work that is being undertaken to improve care and quality of life for people experiencing unexplained loss of consciousness or fainting Isyncope). The aim of the STARS Pioneer Report is inspiring others to improve healthcore services for people livinE with syncope, unexplained loss of consciousness, RAS and PoT5, STARS called for healthcare teams to share case studies of their exemplary work. SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT {CONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2023 H05ting events for both health¢are professlonals• patients, and caregivers. STARS Patients Educatlonal Day was held as part of the annual Heart Rhythm Congress at the Hyatt Regency Hotel In Birmingham. organised by Arrhythmia Alliance- our first in person STARS Patients Day since the covid pandemic. The day wa5 well attended and. sessions included presentations on the various concerns relating to RAS /Syncope in the young, syncope in the elderly, and POTS. It also included a sesslDn with patients, story with the opportunity for questions and answers. All sessions were recorded and hosted online 50 those who could not attend in person Could still access this information. It. Enabled access throughout the year to all patients and care giver5 STARS Patients Day provides the opportunity to hear the latest developments in ￿nCope, and treatment options, from leading medical experts from the UK USA, Canada, Europe and Monaco. STARS Symposia for healthcare professionals was hosted during the Heart Rhythm Congress. Subjects covered were.. . Reflex Syncope: New diagnostic approathes,. Syncope.. Risk stratification in the emergency department; POTS.. and Vasovagal Syncope. Presented by speakers from Europe: Canada,. Monaco,. UK & USA There wa5 a special Anniversary Dinner held on the Monday evening of HRC2023 to celebrate the 30 years of STARS and to mark the occasion special memento gifts We￿ presented to the guests- medical experts in syncope who have shown their dedication and support to STARS throughout the decades. Resources- new publications for 2023 include 6 myths about Syncope, POTS disCUS5ion guide, Syncope discussion guide, Living with RAS and Syncope information sheet. All available online and in paper format. With a full listinE of publications also available on our website www.stars.org.uk Fundrdistng During the recovery from the pandemic and the current economic situation STARS has received significantly reduced donations however we did see many more fundraisers this year through Ju5tGiving, adding a boost to our funds with challenge events such as a Kilt Walk and monthly amounts were raised throLJgh lending of books organised by our STARS Trustee Jane Bateson and has continued throughout 2023. srARS Helpline STARS has received even more enquiries during 2023-the demand increases year on year, and we will continue to meet this demand and work to reduce the strtsEgle to find an appropriate healthcare professional to diagnose correctly and to reduce the number of misdiagnoses for people living with theses conditions, STARS continues to meet demand from patients, caregivers, families, schools, colleges and universities. work environments and care homes plus healthcare professionals and clinics seeking information, education, support and greater awareness. We plan for the next 30 years to be as successful as the previou5 30 years and live in hope that a5 awareness increases so too will detection and diagnosis leading to better outcomes for all those impacted by these conditions. We must a150 focus on ensuring no matter when someone lives, they can access a service near to them. Currently with so few dedicated clinics it is a challenge for so many to find an expert locally. Statt5tics Over all of our STARS websltes there have been 128644 views throughout 2023, Followerlmembers on social media groups are currently at 31555 Email marketing for patients has an open rate of 35.90A. All time members on health unlocked is standing at 1264 SYNCOPE TRusfAND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Flnanclal review The Charity has seen a decrease in income from £243,611 in 2022 to £121.559 in 2023. This is due to a decrease In donation income from £60,585 in 2022 to £17,239 in 2023 and a decrease in grant income from £182,978 in 2022 to £103,667 in 2023. Expendit6Jre increased from £72,311 in 2022 to £79,302 in 2023. The Charity's total funds increased by £42,257 to £605,320 in the financial year. The Trustees hove a Strategic and operational plan in place to ensure stability and growth. Reserves policy The Trustees have a policy of maintaining a level of unrestricted reserves which should ensure that there are adequate funds to meet 3nticip3ted future liabilities. In practice the Trustee5 consider that holding reserves equivalent to a minimum of 3 months, core costs, excluding funds tied up in fixed assets should provide 5ufFicient funds to respond to unexpected adverse Changes in the Charity's funding or activitie5. This equates to a minimum of £15,000 based on the current levels of activity. The Trustees consider that the current level of unrestricted reserves is therefore adequate. Strutture, £overnance and management Governing document The Charity is constituted under a Charity Commission Scheme and is registered Charity number 1084898. The Charity's activities are governed by a Declaration of Trust adopted on 24 November 2000. The Charity was granted charitable status on 6 February 2001. The Trustees who Served during the year and up to the date of signature of the financial statements were: Dr. W P Whitehouse Mrs C L Reid E Bateson Dr M Asgari Recruitment and appointment of trustees The m3nagement of the Charity is responsible of the Trustees who are elected and co-opted under the terms of the Trust deed. There must at all times be a minimum of three Trustees in office. The first Trustees are entitled to hold office for life. New Trustees are appointed by a resolution passed by the Trustees in special meeting. Orgonisotionol structure The Trustees delegate the day to day management of the Charity to the Chief Executive and her 5UPPQrt staff. Induction ond training of trustees New Trustees undergo an orientation process to brief them on their legal obligatlons under Charity law the Charity's governing documents, the committee and decision making process, the business plan and recent financi31 performance of the Charity. During the induttion proce55 they meet key employee5 and other trustees. Trustees are encouraged to attend appropriate external and internal training events which will as515t them in carrying out their role. SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT {CONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2023 Acknowledgements STARS would like to acknowledge the various Trusts, Foundations and Medical Industry that so generously gave their sUPPOrt during the financial year. The Trustees would like to recognise the outstanding contribution made by Trudie Lobban in pursuit of STARS goals and the significant and high impact achievements attained this year through her vision and determination. The Trustees would also like to acknowledge the commitment of the STARS team in their empathetic approach to the delivery of STARS Service throughout the year. Connected Charities Arrhythmia Alliance IA41, a UK registered Charity, number 1107496 is connerted to STARS as an affiliate of the umbrella organisation. Atrial Fibrillation Association IAFAI, a UK registered charity, number 1122442 is connected to STARS as an affiliate of the umbrella organisation. STARS US, Inc, a registered 501(c} non profit organisation in the USA is connected to AFA as an affiliate of the umbre113 organi5ation. The Trustees. report Was approved by the Board of Trustees. Mrs C L Reid Trustee 2 July 2024 SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES I report to the Trustees on my examination of the financial statements of Syncope Trust and Retlex Anoxic Seizure5 (the Charity} for the year ended 31 December 2023. Responsibllitles and basis of report As the Trustees of the Charity you are responsible for the preparation of the financial ststement5 in accordance with the requirements of the Charlties Act 2011 Ithe 2011 Actl. I report In respett of my examination of the Charity's financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Dirertions given by the Charity Commission under settion 145151Ibl of the 2011 Att. Independent examiner's statement Your attention is drawn to the fact that the charity has prepared financial Statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance wlth the Flnancial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 in preference to the Accounting and Reporting by Charities- Statement of Recommended Prartice issued on l April 2005 which is referred to in the extant regulations but has now been withdrawn. understand that this has been done in order for financial statements to provide 3 true and fair view in accordance with Generally Accepted Accounting Practice effettive for reporting periods beginnlng on or after I January 2015. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: accounting records were not kept in respett of the Charity as required by Section 130 Df the 2011 Act,. or the financial statements do not accord with those records", or the financial ststements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities IAccounts and Reportsl Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in thi5 report in order to enable a proper understanding of the financial statements to be reached. TC Group Celixir House Stratford Busines5 & Technology Park Innovation Way, B3nbury Road Strarford-upon-Avon Warwick5hire CV37 7GZ United Kingdom Dated.. 2 July 2024 SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES STATEMEf*lT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2023 Unrestrlcted funds 2023 Unrestricted funds 2022 Note5 Income from: Donations and legacies Charttable activities Investments 17,239 103,667 653 60,585 182,978 48 Totsl incorne 121,559 243,611 Expenditure ofi: Charitable activities 79,302 72,311 Total expendlture 79,302 72,311 Net In￿Me and movement in funds 42,257 171,300 Reconciliation of funds: Fund balances at l January 2023 563,063 391,764 Fund balances at 31 December 2023 605,320 563.064 The statement of linancial activities includes all gains and 1055es recognised in the year. All income and expenditure derive from continuing activities. SYNCOPE TRusfAND REFLEX ANOXIC SEIZURES BALANCE SHEFr ASAT31 DECEMBER 2023 2023 2022 Notes Current assets Debtors Cash at bank and in hand 13 540,379 68,597 479,079 87.173 608,976 566,252 Credltoys: amounts falling due wlthin one year 14 13,656) 13,1881 Net current assets 605,320 563,064 Net assets excluding pension Ilability 605,320 563,064 The funds of the Charity Unrestricted funds 605,320 563,064 605,320 563,064 The financial ststements were approved by the Trustees on 2 July 2024 Mrs C L Reid Trustee SYNCOPE TRusfAND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 A¢¢ountin£ policles Charity information Syncope Trust and Reflex Anoxic Seizures is a unlncorporated Charity. 1.1 Actounttng convention The financial statements have been prepared in accordance with the Charity's Igoverning document], the Charities Act 2011, FRS 102 "The Financial Reportln8 Stsndard applicable in the UK and Republic of Ireland" ("FRS 102,1 and the Charities SORP Accounting and Reporting by Charities.. Statement of Recommended Prattice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" (effective l January 20191. The Charity is a Public Benefit Entity as defined by FRS 102. The Charity has Liken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows. The financial statements have departed from the Charities IAccounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has invDlved following the statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulation5 bLrt which has since been withdrawn. The financial statements are prepared in 5terlin8, which 15 the functional currency of the Charity. Monetary arnounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below. 1.2 Golng concern At the time of approving the financial statements, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees Continue to adopt the going concern basis of accounting in preparing the financial statements. 1,3 Charitable lunds Unrestricted funds are available for use èt the discretlon of the Trustees in furtherance of their charitable objettives. Restricted funds are subject to specific CDnditions by donor5 or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. 1.4 Income Income 15 recognised when the Charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. Cash donations are recognised on receipt. Other donations are recognised once the Char￿ty has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donation5 received under Gift Aid or deed5 of Covenant is recognised at the time of the donation. 10- SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Accounting policles (Contlnued) Legacies are recognised on receipt or otherwise if the Charity has been notified of an impending distribution, the amount is known, and receipt Is expected. If the amount is not known, the legacy is treated a5 a contingent asset. 1.5 Expendlture Expenditure is recognised once there 15 3 legal or constructive obligation to transfer economic benefit to third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably. Expenditure is classified by attivity. The costs of each attivity are made up of the total of dirett costs and shared costs, including SUPPDrt CDsts involved in undertaking each activity. Direct costs attributable to a single artivity are allocated directly to that attivity. Shared costs which contribute to more than one activity and support cost5 which are not attributable to a single activity are apportioned between those activities on a balis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset's use. 1.6 Tangible fixed assets TanEible fixed assets are initially measured at cost and subsequently measured at Cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Fixtures and fittings 50% striaght line The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceed5 and the carrying value of the a55et, and 15 recognised in the statement of financial activities. 1.7 Cash and c85h equivalents Cash and cash equivalents include cash in hand, deposits held at call with banks. other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 1.8 Flnanclal Instruments The Charity has elected to apply the provisions of Settion 11 'Basic Financial Instruments, and Section 12 'Other Financial Instruments1ssue5' of FRS 102 to all of its financial Instruments. Financial instruments are reeognised in the Charity's balance sheet when the Charity becomes party to the contractual provisions of the instrument. Financial asset5 and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recogni5ed amounts and there Is an intention to settle on a net basis or to realise the asset and settle the liability simultaneouslv. 11 SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Attountlng pollcies {Continued) Buslcfinonciol assets Basic financial assets, which include debtors and tash and bank balances, are initially measured 3t transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market fate of interest. Financial assets classified as receivable within one year are not 3mortised. Basicfinancial liabilities Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unle55 the arrangement constitutes a financing transaction, where the debt instrument 15 measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities cla55ified as payable within one year are not arnortised. Debt instruments are sub5eqvently carried at 3mortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment 15 due within one year or less. If not, they are presented as non-current liabilities. Trade creditors a￿ recognised initially at transaction price and subsequently measured at amortised cost using the effertive interest method. Derecognition offlnonclul lirjbilities Financial liabilitie5 are derecognised when the Charity's contractual obligations expire or are discharged or cancelled. 1.9 Employee beneflts The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received. Termination benefits are recognised immediately as an expense when the Charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits. 1.10 Retirement beneflts Payments to defined contribution retirement benefit schemes are charged as an expense as they fall d¢Je. Critlcal accounting estlmates and judgements In the application of the Charity's accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and a5SOClated assumptions are b35Èd on historical experience and other factor5 that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revision5 to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future period5 where the revision affetts both current and future periods. 12- SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Donatlons and legacles Unrestricted Unrestricted funds funds general general 2023 2022 Donation5 and gifts Other fundraising and sponsorship 11,603 5,636 56,558 4,027 Income from charltable activities Vnrestrlcted funds 2023 un￿$tritted funds 2022 Charitable activitie5 Grants and other income 103,667 182,978 Income from investments Unrestrirted Unrestricted funds funds 2023 2022 Interest receivable 653 48 13- SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL sfATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Expenditure on tharftable activities Unrestrirted Unrestricted funds funds 2023 2022 Dlrect costs stsff cost5 Printing, postage and Stationery Recharges Fundr31sing expenses 34,857 6,619 4,8130 786 32,816 1,798 4,911 660 47,062 40,185 Share of support and governance costs (see note 7) Support Governance 30,420 1,820 30,306 1,820 79,302 72,311 Analysls by fund Unrestricted funds 79,302 72,311 Support ¢osts allocated to 3Ctsvitie5 2023 2022 Staff costs Rent Sundries Insurance Consultancy fees Professional fee5 Governance costs 10,711 9,000 435 1,294 8,640 340 1,820 10,492 9,000 238 1,196 8,940 44Q 1,820 32,240 32,126 Analysed between: Unrestricted funds 32,240 32,126 14- SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL sfATEMENTS {CONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2023 Net movement In funds 2023 2022 The net movement In funds is stated after charging/lcreditingl". Fees payable for the independent examination of the charity's financial Statements 1,820 1,820 Employees The average monthly number of employees during the year was.. 2023 Number 2022 Number Employment costs 2023 2022 Wages and salaries Social security costs Other pension costs 30,680 3,361 816 39,060 3.477 771 34,857 43,308 There were no employees whose annual remuneration was more than £60,000. 10 Trustees rumunerntlon and benefit5 There were no trustees. remuneration or other benefits for the year ended 31 December 2023 nor for the year enijed 31 December 2022. Trustee5' expenses There were no trustees, expenses paid for the year ended 31 December 2023 nor for the year ended 31 December 2022. 11 Taxation The charity is exempt from tsxation on its activities because all its income 15 applied for charitsble purposes. 15- SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 12 Tan8lble flxed assets Flxtwes and littin85 Cost At l January 2023 15,895 At 31 December 2023 15.895 Depreciation and Impalrment At l January 2023 15,895 At 31 December 2023 15,895 Carryin8 amount 13 Debtors 2023 2022 Amounts falllng due wlthin one year: Trade debtors Other debtors Prepayments and accrued income 5,000 473,762 317 540,053 326 540,379 479,079 14 Creditors: amounts fa115ng due within one year 2023 2022 Other creditors Accruals and deferred income 1,976 1,680 1,328 1.860 3,656 3,188 15 Retirement benefit schemes 2023 2022 Defined contrlbution schemes Charge to profit or1055 in respect of defined contribution schemes 816 771 16- SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 15 Retirement benefft sthèmes (Continued) The Charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Charity in an independently administered fund. 16 Unrestrlcted funds The unrestricted funds of the charity comprise the unexpended balances of donations and grant5 which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestritted funds bythe trustees for specific purposes. At l January 2023 Inoming resources Resources expended At31 December 2023 General funds 563,063 121.559 179,3021 605.320 Previous year: At l January 2022 Incoming resources Resources expended At31 December 2022 General funds 391,764 243,611 {72,3111 563,064 17 Related party transactions There were no disclosable related party transactions during the year {2022 - none). 18 Transactions with connerted charities During the year, the charity was recharged £4,800 12022.. £4.9111 by Arrhythmia Alliance {AAI, charity number 1107496 for costs incurred on its behalf. RepayinE of services was apportioned from AA of £85,417 12022., £151,728). At the year end, there was a balance due from this charity of £411,31512022.- £330,500). During the year, the charity recharge £25,790 (2022: £26,672) for salary costs incurred on behalf of Atrial Fibrillation Association, charity number 1122442. At the year end, there was a balance due from this charity of £121,75812022- £95,968}. 17-